4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via ITDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver cancer, liver disorder, neoplasmRecruitingPhase 22024-07-01NCT06482801
Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid TumorsSolid Tumor, AdultRecruitingPhase 12024-06-26NCT06195293
Study of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLCNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingEarly phase 12024-06-25NCT05060796
Engineered TILs/CAR-TILs to Treat Advanced Solid TumorsDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, brain disorder, breast cancer, breast disorder, breast neoplasm, central nervous system cancer, central nervous system disorder, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, liver cancer, liver disorder, lung cancer, lung disorder, lung neoplasm, neoplasm, nervous system disorder, respiratory system disorder, respiratory tract neoplasm, skin disorderRecruitingPhase 12024-06-25NCT04842812